Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

U.S. military vehicles drive on a road in the town of Tal Tamr on October 20, 2019, after pulling out of their base. Photo: Delil Souleiman/AFP via Getty Images

The State Department distributed talking points to American embassies on Oct. 17 that included warnings that Turkey’s military offensive against Kurds in northern Syria is undermining counter-ISIS efforts and endangering innocent civilians, Vox's Alex Ward reports.

Why it matters: The talking points contradict President Trump's optimism about the Turkish incursion that followed his decision to remove troops from northern Syria. They indicate that members of his administration, especially career diplomats, are worried about the long-term consequences of the decision.

What they're saying: According to a copy of the talking points obtained by Vox, the State Department’s Bureau of Near Eastern Affairs wrote that "Turkey’s military offensive is severely undermining counter-ISIS efforts, endangering innocent civilians, and threatening peace, security, and stability in the region."

  • "Turkey does not appear to be mitigating the humanitarian impact of its invasion and occupation of some parts of northeast Syria," the cable adds. The U.S. has "called on Turkey to investigate possible violations of international humanitarian law, especially unlawful attacks against civilians and civilian infrastructure."
  • The talking points also note that the department has withdrawn humanitarian and stabilization assistance advisers from northern Syria, which will make it difficult to implement the $50 million aid that the U.S. plans to distribute, per Vox.

Meanwhile, Trump has brushed off concerns that ISIS fighters could take advantage of the chaos and escape prisons and detention camps. On Oct. 9, Trump said ISIS fighters would defect to Europe if they escaped.

  • So far, at least 950 ISIS supporters have escaped camps for displaced people.
  • On Oct. 16, the president said that "the Kurds are much safer right now. But the Kurds know how to fight, and as I said, they're not angels. They're not angels. ... I wish them all a lot of luck."

Of note: The State Department released the talking points before Vice President Mike Pence and Secretary of State Mike Pompeo met with Turkish President Recep Tayyip Erdogan and agreed to a temporary ceasefire that would force Kurdish forces to evacuate the area.

  • A State Department official told Vox the talking points have not been updated since the ceasefire.

Go deeper: Pentagon may struggle to contain ISIS in Syria

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

7 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios